| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-11 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-09 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-08 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-07 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |